Article Text

Download PDFPDF
Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis
  1. M Binder1,
  2. M Uhl2,
  3. T Wiech3,
  4. F Kollert1,
  5. J Thiel1,
  6. J O Sass4,
  7. U A Walker5,
  8. H H Peter1,
  9. K Warnatz1
  1. 1Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Freiburg, Germany
  2. 2Department of Radiology, RKK Freiburg, Freiburg, Germany
  3. 3Institute of Pathology, University Hospital Freiburg, Freiburg, Germany
  4. 4Laboratory of Clinical Biochemistry and Metabolism, Centre for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany
  5. 5Basel University Department of Rheumatology, Felix-Platter Spital, Basel, Switzerland
  1. Correspondence to Professor Dr Klaus Warnatz, Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Hugstetterstrasse 55, D-79106 Freiburg, Germany; klaus.warnatz{at}

Statistics from

Chronic periaortitis is a fibro-inflammatory disease of unknown aetiology with histopathological and laboratory findings suggesting an IgG4-related sclerosing disease in a subgroup of patients.1,,3 Due to its inflammatory character and associated autoimmune phenomena, different immunosuppressive regimens have been suggested for treatment.4,,9

In this study, we retrospectively examined the response to immunosuppressive treatment of 35 patients with chronic periaortitis applying the same study design as before.5 Imaging studies were performed and serum IgG4 levels were measured both at the time of diagnosis and during follow-up. Retroperitoneal tissue was examined histologically in four patients. Emphasis has been placed on the evaluation of cyclophosphamide in the induction therapy and the hitherto unknown value of serum IgG4 measurements in disease monitoring.

The Wilcoxon signed-rank test was used for statistical analysis of the imaging findings before and after induction therapy; for the remaining analyses, the Mann–Whitney U test was used. Data are reported as mean±SD or as median (range).

In 21 patients induction therapy was started with cyclophosphamide, and the remaining …

View Full Text


  • Competing interests None.

  • Ethics approval Ethics Committee of the University Hospital Freiburg.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.